Activating STAT6 mutations in follicular lymphoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Follicular lymphoma (FL) is a common non-Hodgkin lymphoma.
• FL pathogenesis involves complex cell-intrinsic and cell-extrinsic factors.
• Understanding the genetic underpinnings of FL is crucial for improving outcomes.

Purpose of the Study:

• To investigate the genetic basis of follicular lymphoma.
• To identify recurrent mutations contributing to FL development.
• To elucidate the functional consequences of identified mutations.

Main Methods:

• Whole-exome sequencing of 114 follicular lymphoma cases.
• Functional assays including transfection/luciferase reporter assays.
• Cell-based assays and structural modeling of STAT6.

Main Results:

• Recurrent activating mutations in the transcription factor STAT6 were identified in 11% of FL cases.
• A novel mutation hotspot at STAT6 amino acid residue 419 was discovered.
• Mutant STAT6 demonstrated enhanced transactivation, increased IL-4-induced gene activation, and facilitated nuclear residency.

Conclusions:

• The IL-4/JAK/STAT6 signaling pathway is a significant driver of follicular lymphoma pathogenesis.
• STAT6 mutations represent a key genetic event in a subset of FL.
• These findings offer potential therapeutic targets for FL treatment.